GlucoTrack, Inc. Files 8-K: Material Agreement, Debt, Equity Sales
Ticker: GCTK · Form: 8-K · Filed: Jul 1, 2024 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $100,000, $0.001, $1,000,000, $4.95 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
TL;DR
GlucoTrack just dropped an 8-K: new deal, debt, and sold stock. Watch this space.
AI Summary
On July 1, 2024, GlucoTrack, Inc. (formerly Integrity Applications, Inc.) entered into a material definitive agreement. The company also reported the creation of a direct financial obligation and unregistered sales of equity securities. The filing details financial statements and exhibits related to these events.
Why It Matters
This 8-K filing indicates significant corporate actions by GlucoTrack, Inc., including new agreements, financial obligations, and equity transactions, which could impact its financial standing and stock performance.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements, financial obligations, and unregistered equity sales, suggesting potential financial shifts and regulatory scrutiny.
Key Players & Entities
- GlucoTrack, Inc. (company) — Registrant
- Integrity Applications, Inc. (company) — Former company name
- July 1, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by GlucoTrack, Inc. on July 1, 2024?
The filing states that GlucoTrack, Inc. entered into a material definitive agreement on July 1, 2024, but the specific details of this agreement are not provided in the provided text.
What type of direct financial obligation was created by GlucoTrack, Inc.?
The filing indicates the creation of a direct financial obligation by GlucoTrack, Inc., but the specific details or amount of this obligation are not detailed in the provided text.
Were there any unregistered sales of equity securities by GlucoTrack, Inc.?
Yes, the filing explicitly lists 'Unregistered Sales of Equity Securities' as an item information, indicating such sales occurred.
What was GlucoTrack, Inc.'s former company name?
GlucoTrack, Inc.'s former company name was Integrity Applications, Inc., with a date of name change on December 3, 2010.
Where is GlucoTrack, Inc. incorporated and what is its business address?
GlucoTrack, Inc. is incorporated in Delaware and its business address is 301 Rte 17 North, Suite 800, Rutherford, NJ 07070.
Filing Stats: 826 words · 3 min read · ~3 pages · Grade level 10.3 · Accepted 2024-07-01 17:25:24
Key Financial Figures
- $100,000 — es in the aggregate principal amount of $100,000 (the "Notes") and warrants (the "Warran
- $0.001 — f the Company's common stock, par value $0.001 per share (the "Common Stock"). The clo
- $1,000,000 — l in an amount equal to or in excess of $1,000,000 (the "Maturity Date"). The Company may
- $4.95 — Each Warrant has an exercise price of $4.95 per share. The Warrants are immediately
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex4-1.htm (EX-4.1) — 72KB
- ex10-1.htm (EX-10.1) — 38KB
- ex10-2.htm (EX-10.2) — 13KB
- 0001493152-24-025858.txt ( ) — 360KB
- gctk-20240701.xsd (EX-101.SCH) — 3KB
- gctk-20240701_lab.xml (EX-101.LAB) — 33KB
- gctk-20240701_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Glucotrack, Inc. Date: July 1, 2024 By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer